Recent Updates
Recently added Catalysts
VTRS Positive Sentiment Score: 60/100

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024 Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) will announce its first quarter 2024 financial results on May 9, 2024, prior to the opening of the U.S. markets. CEO Scott A. Smith and company executives will lead a webcast at 8:30 a.m. ET for discussion of the results. Interested parties can listen to the call via a dedicated webcast or by phone. A recording of the call will be accessible afterward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is set to report its first quarter 2024 financial results, indicating active business operations.
  • The company emphasizes its commitment to providing high-quality medicines globally to a large patient base.
  • A live webcast will allow investors and the public to engage directly with company executives.

Full Press Release Details

PITTSBURGH , April 16, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ) will report its first quarter 2024 financial results on Thursday, May 9, 2024 , before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris Viatris Inc . ( NASDAQ : VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris . We are headquartered in the U.S ., with global centers in Pittsburgh , Shanghai and Hyderabad , India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).
SOURCE Viatris Inc.

21 %

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris report its Q1 2024 financial results?

Viatris will report its Q1 2024 results on May 9, 2024, before U.S. market opening.

How can I join Viatris's Q1 financial results webcast?

You can join the webcast at investor.viatris.com or call 844.308.3344.

What is Viatris's mission?

Viatris aims to empower people worldwide to live healthier at every stage of life.

Where are Viatris's global centers located?

Viatris has global centers in Pittsburgh, Shanghai, and Hyderabad, India.

How many patients does Viatris serve annually?

Viatris supplies high-quality medicines to approximately 1 billion patients each year.

Last updated: Apr 16, 2024